Comparison of Two Strategies for Endotracheal Tube Cuff Underinflation Prevention During Invasive Mechanical Ventilation (CONTIPRESS)
Primary Purpose
Acute Brain Injury, Brain Injuries
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Tracoe Smart CuffmanagerTM
Sponsored by
About this trial
This is an interventional other trial for Acute Brain Injury focused on measuring Endotracheal tube, ventilator's associated pneumonia, intensive care unit, orotracheal intubation
Eligibility Criteria
Inclusion Criteria:
- with severe acute brain damage
- admitted in the ICU for less than 48 hours
- and expected to receive invasive mechanical ventilation (through orotracheal tube with a low pressure-high volume cuff) for at least 48 hours after inclusion.
Exclusion Criteria:
- change in the upper airway management within the 48 hours following the inclusion (extubation or change in the tracheal tube or tracheostomy)
- pregnancy, moribund status.
Sites / Locations
- Chu de Nantes
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
continuous adjustment strategy
usual care
Arm Description
patients assigned to the continuous adjustment strategy, in addition to standard care, the Tracoe Smart CuffmanagerTM will be connected to the tracheal cuff
patients with usual care
Outcomes
Primary Outcome Measures
Incidence of underinflation episodes
The primary outcome is to test whether the Tracoe Smart CuffmanagerTM reduces the incidence of underinflation episodes, as compared with the intermittent strategy of Pcuff control. Therefore, a comparison, between the 2 groups, of the incidence of Pcuff <20 cmH2O measurements will be performed.
Time Frame: Within the 2 days following the inclusion, all the intermittent Pcuff measurements will be collected as well as the incidence of Pcuff manual adjustments
Secondary Outcome Measures
incidence of Pcuff >30 cmH2O measurements (overinflation episodes)
As secondary objective, a comparison, between the 2 groups, of the incidence of Pcuff >30 cmH2O measurements (overinflation episodes) will be performed.
Furthermore, the incidence of early ventilator-associated pneumonia will be compared between the 2 groups.
Duration of mechanical ventilation
ICU length of stay
ICU mortality
occurrence of early ventilator-associated pneumonia
Full Information
NCT ID
NCT03330379
First Posted
October 31, 2017
Last Updated
August 30, 2019
Sponsor
Nantes University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03330379
Brief Title
Comparison of Two Strategies for Endotracheal Tube Cuff Underinflation Prevention During Invasive Mechanical Ventilation
Acronym
CONTIPRESS
Official Title
Comparison of Two Strategies for the Prevention of Endotracheal Tube Cuff Underinflation During Invasive Mechanical Ventilation: Intermittent Versus Continuous Cuff Pressure Control - A Randomised Controlled Study
Study Type
Interventional
2. Study Status
Record Verification Date
August 2019
Overall Recruitment Status
Completed
Study Start Date
March 1, 2018 (Actual)
Primary Completion Date
July 31, 2019 (Actual)
Study Completion Date
July 31, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Nantes University Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
During invasive mechanical ventilation, maintaining endotracheal tube cuff pressure (Pcuff) around 25 cmH2O is recommended for sealing the upper airways. The continuous control of Pcuff with a simple mechanical device, the Tracoe Smart CuffmanagerTM, has never been assessed. The investigators hypothesize that the Tracoe Smart CuffmanagerTM would allow a reduction of the incidence of underinflation episodes, as compared with the intermittent strategy of Pcuff control.
Detailed Description
During invasive mechanical ventilation, maintaining a tracheal cuff pressure (Pcuff) around 25 cmH2O is recommended to prevent cuff over- (> 30 cmH2O) and underinflation (< 20 cmH2O), identified as risk factors for tracheal ischemic damage and for oropharyngeal microaspirations, respectively. Intermittent measurements with intermittent adjustments of Pcuff is the widely used strategy but, between measurements, over- and underinflation episodes could occur. Devices allowing a continuous control of Pcuff are therefore appealing. As microaspiration is the most relevant mechanism for ventilator-associated pneumonia (VAP), the use of such devices may decrease the incidence of VAP for instance. To the knowledge of the investigators, the continuous control of Pcuff with a simple mechanical device, the Tracoe Smart CuffmanagerTM, has never been assessed. The investigators hypothesize that the Tracoe Smart CuffmanagerTM would allow a reduction of the incidence of underinflation episodes, as compared with the intermittent strategy of Pcuff control. As secondary objectives, the investigators aim to assess the impact of the use of the Tracoe Smart CuffmanagerTM on the incidence of overinflation episodes and on the incidence of early ventilator-associated pneumonia. A homogenous population will be studied for this purpose: patients admitted with severe acute brain damage.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Brain Injury, Brain Injuries
Keywords
Endotracheal tube, ventilator's associated pneumonia, intensive care unit, orotracheal intubation
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Actual)
8. Arms, Groups, and Interventions
Arm Title
continuous adjustment strategy
Arm Type
Experimental
Arm Description
patients assigned to the continuous adjustment strategy, in addition to standard care, the Tracoe Smart CuffmanagerTM will be connected to the tracheal cuff
Arm Title
usual care
Arm Type
No Intervention
Arm Description
patients with usual care
Intervention Type
Device
Intervention Name(s)
Tracoe Smart CuffmanagerTM
Intervention Description
In patients randomly assigned to the continuous adjustment strategy, in addition to standard care, the Tracoe Smart CuffmanagerTM will be connected to the tracheal cuff. Within the 2 days following the inclusion, all the intermittent Pcuff measurements will be collected as well as the incidence of Pcuff manual adjustments
Primary Outcome Measure Information:
Title
Incidence of underinflation episodes
Description
The primary outcome is to test whether the Tracoe Smart CuffmanagerTM reduces the incidence of underinflation episodes, as compared with the intermittent strategy of Pcuff control. Therefore, a comparison, between the 2 groups, of the incidence of Pcuff <20 cmH2O measurements will be performed.
Time Frame: Within the 2 days following the inclusion, all the intermittent Pcuff measurements will be collected as well as the incidence of Pcuff manual adjustments
Time Frame
Day2
Secondary Outcome Measure Information:
Title
incidence of Pcuff >30 cmH2O measurements (overinflation episodes)
Description
As secondary objective, a comparison, between the 2 groups, of the incidence of Pcuff >30 cmH2O measurements (overinflation episodes) will be performed.
Furthermore, the incidence of early ventilator-associated pneumonia will be compared between the 2 groups.
Time Frame
Within the 2 days following the inclusion
Title
Duration of mechanical ventilation
Time Frame
Within the 2 days following the inclusion
Title
ICU length of stay
Time Frame
Within the 2 days following the inclusion
Title
ICU mortality
Time Frame
Within the 2 days following the inclusion
Title
occurrence of early ventilator-associated pneumonia
Time Frame
During the first two weeks of hospital stay
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
with severe acute brain damage
admitted in the ICU for less than 48 hours
and expected to receive invasive mechanical ventilation (through orotracheal tube with a low pressure-high volume cuff) for at least 48 hours after inclusion.
Exclusion Criteria:
change in the upper airway management within the 48 hours following the inclusion (extubation or change in the tracheal tube or tracheostomy)
pregnancy, moribund status.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jérôme Dauvergne
Organizational Affiliation
Nantes University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Chu de Nantes
City
Nantes
ZIP/Postal Code
44093
Country
France
12. IPD Sharing Statement
Citations:
PubMed Identifier
32376293
Citation
Dauvergne JE, Geffray AL, Asehnoune K, Rozec B, Lakhal K. Automatic regulation of the endotracheal tube cuff pressure with a portable elastomeric device. A randomised controlled study. Anaesth Crit Care Pain Med. 2020 Jun;39(3):435-441. doi: 10.1016/j.accpm.2020.04.007. Epub 2020 May 4.
Results Reference
derived
Learn more about this trial
Comparison of Two Strategies for Endotracheal Tube Cuff Underinflation Prevention During Invasive Mechanical Ventilation
We'll reach out to this number within 24 hrs